Do Young Hyeon
Overview
Explore the profile of Do Young Hyeon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chae S, Nam D, Hyeon D, Hong A, Lee T, Kim S, et al.
iScience
. 2021 Apr;
24(4):102325.
PMID: 33889821
Neuroblastoma is a solid, heterogeneous pediatric tumor. Chemotherapy is widely used to treat neuroblastoma. However, dose-dependent responses and chemoresistance mechanisms of neuroblastoma cells to anticancer drugs remain challenging. Here, we...
12.
Yoo J, Hyeon D, Shin Y, Kim S, You Y, Kim D, et al.
Sci Rep
. 2021 Jan;
11(1):2392.
PMID: 33504832
Preterm birth (PTB), defined as birth at less than 37 weeks of gestation, is a major determinant of neonatal mortality and morbidity. Early diagnosis of PTB risk followed by protective...
13.
RUNX3 methylation drives hypoxia-induced cell proliferation and antiapoptosis in early tumorigenesis
Lee S, Hyeon D, Yoon S, Jeong J, Han S, Jang J, et al.
Cell Death Differ
. 2020 Oct;
28(4):1251-1269.
PMID: 33116296
Inactivation of tumor suppressor Runt-related transcription factor 3 (RUNX3) plays an important role during early tumorigenesis. However, posttranslational modifications (PTM)-based mechanism for the inactivation of RUNX3 under hypoxia is still...
14.
Han M, Kwon M, Ko B, Hyeon D, Lee D, Kim H, et al.
J Cell Biol
. 2020 Oct;
219(12).
PMID: 33090185
Dendrite pathology is frequently observed in various neurodegenerative diseases (NDs). Although previous studies identified several pathogenic mediators of dendrite defects that act through loss of function in NDs, the underlying...
15.
Lee J, Hyeon D, Hwang D
Exp Mol Med
. 2020 Sep;
52(9):1428-1442.
PMID: 32929225
Advances in single-cell isolation and barcoding technologies offer unprecedented opportunities to profile DNA, mRNA, and proteins at a single-cell resolution. Recently, bulk multiomics analyses, such as multidimensional genomic and proteogenomic...
16.
Roh J, Lee J, Sung Y, Oh J, Hyeon D, Kim Y, et al.
Oncogene
. 2020 Jul;
39(36):5876-5887.
PMID: 32728173
KRAS-mutant non-small cell lung cancer (NSCLC) is a major lung cancer subtype that leads to many cancer-related deaths worldwide. Although numerous studies on KRAS-mutant type NSCLC have been conducted, new...
17.
Kim E, Lee K, Hyeon D, Kyung M, Jun K, Seo S, et al.
Cell Host Microbe
. 2020 Feb;
27(3):345-357.e6.
PMID: 32078802
Although the gut microbiome is generally symbiotic or commensal, some microbiome members become pathogenic under certain circumstances. However, the factors driving this pathogenic switch are largely unknown. Pathogenic bacteria can...
18.
Lee N, Jae Y, Kim M, Cho T, Lee C, Hong Y, et al.
FEBS J
. 2020 Feb;
287(17):3841-3870.
PMID: 32003140
Microglia (MG), the principal neuroimmune sentinels in the brain, continuously sense changes in their environment and respond to invading pathogens, toxins, and cellular debris, thereby affecting neuroinflammation. Microbial pathogens produce...
19.
Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L, et al.
Elife
. 2019 Aug;
8.
PMID: 31429823
CCN1 (CYR61) stimulates active angiogenesis in various tumours, although the mechanism is largely unknown. Here, we report that CCN1 is a key regulator of endothelial tip cell activity in angiogenesis....
20.
Min B, Park S, Kang H, Kim D, Ham H, Ha C, et al.
Front Immunol
. 2019 May;
10:944.
PMID: 31134063
Metabolic reprogramming during macrophage polarization supports the effector functions of these cells in health and disease. Here, we demonstrate that pyruvate dehydrogenase kinase (PDK), which inhibits the pyruvate dehydrogenase-mediated conversion...